Condition
Elderly Metastatic Colorectal Cancer Patients
Total Trials
3
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Active Not Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT03449914Active Not RecruitingPrimary
The GOLD Study: G8 in OLDer Patients
NCT03451370Active Not RecruitingPrimary
First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
NCT02904031Phase 2UnknownPrimary
Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients
Showing all 3 trials